4//SEC Filing
Ganot Ilan 4
Accession 0000950170-25-022199
CIK 0001707502other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:05 PM ET
Size
10.8 KB
Accession
0000950170-25-022199
Insider Transaction Report
Form 4
Ganot Ilan
Director
Transactions
- Exercise/Conversion
Common Stock
2025-02-13+4,861→ 16,550 total(indirect: By Spouse) - Sale
Common Stock
2025-02-14$3.96/sh−1,711$6,776→ 14,839 total(indirect: By Spouse) - Exercise/Conversion
Restricted Stock Units
2025-02-13−4,861→ 14,583 total(indirect: By Spouse)→ Common Stock (4,861 underlying)
Holdings
- 19,394(indirect: See Footnote)
Common Stock
- 98,690
Common Stock
Footnotes (5)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Represents 94,648 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
- [F3]This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.
- [F4]Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
- [F5]On February 13, 2024 (the "Grant Date") Ms. Ganot was granted 19,444 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001727460
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 4:05 PM ET
- Size
- 10.8 KB